サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1663503

血管内治療装置の世界市場：製品別・処置別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Endovascular Treatment Devices Market, By Product, By Procedure, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血管内治療装置の世界市場：製品別・処置別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年01月04日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

血管内治療装置の市場規模は2024年に34億5,033万米ドルとなり、2025年から2032年にかけてCAGR 9.50%で拡大

血管内治療装置の市場力学

血管疾患の増加

末梢動脈疾患 (PAD)、大動脈瘤、静脈血栓塞栓症 (VTE) などの血管疾患は、人口の高齢化、座りがちなライフスタイル、肥満、高血圧、糖尿病などの危険因子により、より広まりつつあります。世界保健機関 (WHO) によると、血管障害を含む心血管系疾患による死亡者数は年間約1,790万人で、全世界の死亡者数の32%を占めています。血流を回復させ、生命を脅かす合併症を予防するために効果的な介入を必要とする患者が増加しており、高度な治療オプションに対する需要が高まっています。ステントグラフト、バルーンカテーテル、血栓除去システムなどの血管内装置は、これらの病態を管理するための低侵襲ソリューションを提供します。これらは、従来の開腹手術に代わる、より安全で効率的な選択肢を提供し、入院期間、回復時間、術後合併症のリスクを軽減します。さらに、医療インフラを改善し、血管疾患の早期診断と治療に対する意識を高めるための政府の取り組みが、市場の拡大をさらに後押ししています。例えば、心血管リスク軽減をターゲットとした国民健康キャンペーンや最新の血管治療技術の統合が成長を促進しています。

血管内治療装置市場：主な考察

  • 調査アナリストの分析によると、世界市場は予測期間 (2025-2032年) に約9.50%のCAGRで毎年成長すると推定されます。
  • 製品別では、ステントが2024年に最大市場シェアを示すと予測されました。
  • エンドユーザー別では、病院が2024年の主要セグメントです。
  • 地域別では、北米が2024年に収益を上げる主要市場となっています。

血管内治療装置市場：セグメンテーション分析

血管内治療デバイスの世界市場は、製品、処置、エンドユーザー、地域別に区分されます。

市場は製品別に3つに分類されます：ステント、バルーンカテーテル、下大静脈フィルターです。ステントは、血流を効率的に回復させ、再狭窄のリスクを低減することにより、動脈閉塞の治療に広く使用されているため、市場を独占しています。さらに、薬剤溶出性ステントや生体吸収性ステントの進歩が長期的な治療成績を向上させ、市場の主導権を握り続ける原動力となっています。

市場はエンドユーザー別に病院、外来手術センター、専門クリニックの3つに分類されます。病院は、高度な医療インフラ、専門の血管治療ユニット、複雑な血管内治療に必要な熟練した専門家を備えているため、市場を独占しています。さらに、患者の流入が多く、術後ケア施設が利用可能であることから、病院が血管内治療に選ばれています。

血管内治療装置市場：地域別分析

北米は、血管疾患の罹患率の高さ、高度な医療システム、低侵襲手技の普及によって世界市場をリードしています。米国心臓協会によると、心血管系疾患は依然として米国の主要な死因であり、革新的な血管内治療ソリューションの需要をさらに押し上げています。さらに、有利な償還政策と継続的な製品の進歩が、この地域の優位性を強化しています。欧州は、高齢化、医療支出の増加、心血管疾患管理を促進する政府の取り組みに支えられ、大きな市場シェアを占めています。ドイツ、英国、フランスなどの国々は、その強固な医療システムと医療機器の技術的進歩により大きく貢献しています。アジア太平洋は、医療意識の高まり、末梢動脈疾患の症例増加、医療インフラの改善などにより、最も速い成長が見込まれています。中国、インド、日本などの国々では、急速な都市化、ライフスタイルの変化、高齢者人口の増加がさらに市場拡大に寄与しています。さらに、近代的な医療施設に対する政府の投資と医療へのアクセスの向上が、この地域の需要を促進しています。

血管内治療装置市場：競合情勢

血管内治療機器市場の競合情勢は、技術革新、製品の差別化、戦略的提携に焦点を当てた主要企業間の激しい敵対関係によって特徴付けられます。各社は、薬剤溶出性ステントや生体吸収性ステント、高度塞栓防止システム、新規血栓除去デバイスなど、安全性、有効性、耐久性が向上した次世代デバイスを導入するための研究開発に多額の投資を行っています。市場参入企業はまた、多様な血管病態における低侵襲ソリューションに対する需要の高まりに対応するため、ポートフォリオを拡大しています。戦略的パートナーシップ、合併、買収は、市場での存在感を高め、技術的進歩を推進し、地理的範囲を拡大するための一般的な戦術です。さらに各企業は、厳しい安全基準を満たし、世界医療規制へのコンプライアンスを確保しながら、競争力を得るために、規制当局の承認と臨床試験を重視しています。AI主導の診断とスマート血管内治療技術の採用の増加が市場を形成し、精度の向上と個別化治療の機会を生み出しています。競争力のある価格設定、強固な流通網、販売後のサポートも市場シェア維持に重要な役割を果たしています。高度な血管治療ソリューションの需要が高まるにつれ、競合の激化が予想され、このダイナミックな分野における継続的な技術革新と患者転帰の改善が促進されます。

目次

第1章 血管内治療装置市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 血管内治療装置の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 血管内治療装置市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 血管内治療装置市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 血管内治療装置の市場情勢

  • 血管内治療装置の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 血管内治療装置市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • ステント
    • バルーンカテーテル
    • 下大静脈フィルター
    • その他

第8章 血管内治療装置市場：処置別

  • 概要
    • セグメント別シェア分析：処置別
    • 血管形成術
    • 動脈瘤修復術
    • 血栓除去術
    • その他

第9章 血管内治療装置市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院
    • 外来手術センター
    • 専門クリニック
    • その他

第10章 血管内治療装置市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ (LATAM)
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ (MEA)
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：血管内治療装置業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Boston Scientific Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Johnson &Johnson Services, Inc.
    • Terumo Corporation
    • Cook Group Incorporated
    • Edwards Lifesciences Corporation
    • WL Gore &Associates, Inc.
    • Philips Healthcare
    • Siemens Healthineers
    • Cardinal Health
    • Stryker Corporation
    • Baxter International Inc.
    • Asahi Intecc Co., Ltd.
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4673

REPORT HIGHLIGHT

Endovascular Treatment Devices Market size was valued at US$ 3,450.33 Million in 2024, expanding at a CAGR of 9.50% from 2025 to 2032.

Endovascular treatment devices are medical instruments used in minimally invasive procedures to treat various vascular diseases by accessing blood vessels through small incisions or punctures. These devices include stents, balloon catheters, embolic protection devices, and thrombectomy systems, which are essential for managing conditions like aneurysms, arterial blockages, and venous thromboembolism. Unlike traditional open surgeries, endovascular treatments offer a less invasive alternative, reducing patient trauma, hospital stays, and recovery times. The need for endovascular treatment devices arises from the growing prevalence of cardiovascular and peripheral vascular diseases driven by aging populations, sedentary lifestyles, and increasing rates of obesity and diabetes. These devices enable precision-targeted interventions, improving clinical outcomes and patient safety. For example, stent grafts reinforce weakened blood vessels, preventing potentially fatal ruptures, while thrombectomy devices remove life-threatening blood clots with minimal risk. Their importance lies in transforming the management of complex vascular conditions. Endovascular procedures significantly reduce morbidity and mortality rates compared to conventional surgeries. They also lower healthcare costs by minimizing postoperative complications and facilitating faster recovery. Furthermore, technological advancements in device design and materials continue to enhance the effectiveness and durability of treatments, driving the adoption of endovascular solutions as a cornerstone in modern vascular care.

Endovascular Treatment Devices Market- Market Dynamics

Increasing prevalence of vascular diseases

Vascular conditions, including peripheral artery disease (PAD), aortic aneurysms, and venous thromboembolism (VTE), are becoming more widespread due to aging populations, sedentary lifestyles, and risk factors such as obesity, hypertension, and diabetes. According to the World Health Organization (WHO), cardiovascular diseases, which include vascular disorders, account for nearly 17.9 million deaths annually, representing 32% of all global deaths. A growing number of patients require effective interventions to restore blood flow and prevent life-threatening complications, increasing the demand for advanced treatment options. Endovascular devices, such as stent grafts, balloon catheters, and thrombectomy systems, offer minimally invasive solutions to manage these conditions. They provide a safer and more efficient alternative to traditional open surgeries, reducing hospital stays, recovery times, and the risk of postoperative complications. Furthermore, government initiatives to improve healthcare infrastructure and raise awareness about early diagnosis and treatment of vascular diseases further support market expansion. For example, national health campaigns targeting cardiovascular risk reduction and the integration of modern vascular care technologies are fostering growth.

Endovascular Treatment Devices Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.50% over the forecast period (2025-2032)
  • Based on Product segmentation, Stents was predicted to show maximum market share in the year 2024
  • Based on End-User segmentation, Hospitals was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Endovascular Treatment Devices Market- Segmentation Analysis:

The Global Endovascular Treatment Devices Market is segmented on the basis of Product, Procedure, End-User and Region.

The market is divided into three categories based on Product: Stents, Balloon Catheters and Inferior Vena Cava Filters. Stents dominate the market due to their widespread use in treating arterial blockages by restoring blood flow efficiently and reducing the risk of restenosis. Additionally, advancements in drug-eluting and bioresorbable stents enhance long-term outcomes, driving their continued market leadership.

The market is divided into three categories based on End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics. Hospitals dominate the market because they are equipped with advanced medical infrastructure, specialized vascular care units, and skilled professionals required for complex endovascular procedures. Additionally, the higher patient inflow and availability of post-operative care facilities make hospitals the preferred choice for vascular treatments.

Endovascular Treatment Devices Market- Geographical Insights

North America leads the global market, driven by a high incidence of vascular diseases, advanced healthcare systems, and widespread adoption of minimally invasive procedures. According to the American Heart Association, cardiovascular diseases remain a leading cause of death in the United States, further boosting the demand for innovative endovascular solutions. Additionally, favorable reimbursement policies and continuous product advancements strengthen the region's dominance. Europe holds a substantial market share, supported by an aging population, increased healthcare spending, and government initiatives promoting cardiovascular disease management. Countries like Germany, the United Kingdom, and France contribute significantly due to their robust healthcare systems and technological advancements in medical devices. The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare awareness, increasing cases of peripheral artery diseases, and improvements in healthcare infrastructure. Rapid urbanization, lifestyle changes, and a growing elderly population in countries like China, India, and Japan further contribute to market expansion. Moreover, government investments in modern healthcare facilities and increasing access to medical treatments are propelling demand in this region.

Endovascular Treatment Devices Market- Competitive Landscape:

The competitive landscape of the endovascular treatment devices market is characterized by intense rivalry among key players focusing on innovation, product differentiation, and strategic collaborations. Companies are investing heavily in research and development to introduce next-generation devices with improved safety, efficacy, and durability, such as drug-eluting and bioresorbable stents, advanced embolic protection systems, and novel thrombectomy devices. Market participants are also expanding their portfolios to cater to the growing demand for minimally invasive solutions across diverse vascular conditions. Strategic partnerships, mergers, and acquisitions are common tactics to enhance market presence, drive technological advancements, and expand geographic reach. Additionally, players are emphasizing regulatory approvals and clinical trials to gain a competitive edge while meeting stringent safety standards and ensuring compliance with global healthcare regulations. The increasing adoption of AI-driven diagnostics and smart endovascular technologies is shaping the market, creating opportunities for enhanced precision and personalized treatment. Competitive pricing, robust distribution networks, and post-sales support also play critical roles in maintaining market share. As the demand for advanced vascular treatment solutions grows, the competitive intensity is expected to rise, fostering continuous innovation and improved patient outcomes in this dynamic sector.

Recent Developments:

  • In June 2024, Boston Scientific announced an agreement to acquire Silk Road Medical, Inc., a company specializing in devices for transcarotid artery revascularization (TCAR), a minimally invasive procedure aimed at preventing strokes in patients with carotid artery disease.
  • In July 2024, Sensome signed an exclusive distribution agreement with Cosmotec in Japan for its clot-sensing guidewire. This partnership allows Cosmotec to commercialize Sensome's innovative technology, which is designed to detect blood clots in real time during endovascular procedures, improving clinical decision-making and patient outcomes. The agreement marks an important step in Sensome's expansion into the Japanese market, enhancing access to its cutting-edge medical devices.
  • In November 2024, Solaris Endovascular, Inc. has launched in the U.S. to develop solutions for dialysis access in end-stage kidney disease and peripheral artery disease treatment. Its flagship product, the Solaris SX vascular stent graft, aims to reduce restenosis and improve patency with advanced technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Boston Scientific Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Johnson & Johnson Services, Inc.
  • Terumo Corporation
  • Cook Group Incorporated
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates, Inc.
  • Philips Healthcare
  • Siemens Healthineers
  • Cardinal Health
  • Stryker Corporation
  • Baxter International Inc.
  • Asahi Intecc Co., Ltd.
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Stents
  • Balloon Catheters
  • Inferior Vena Cava Filters
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PROCEDURE - MARKET ANALYSIS, 2019 - 2032

  • Angioplasty
  • Aneurysm Repair
  • Thrombectomy
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Endovascular Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Endovascular Treatment Devices Market Snippet by Product
    • 2.1.2. Endovascular Treatment Devices Market Snippet by Procedure
    • 2.1.3. Endovascular Treatment Devices Market Snippet by End-User
    • 2.1.4. Endovascular Treatment Devices Market Snippet by Country
    • 2.1.5. Endovascular Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Endovascular Treatment Devices Key Market Trends

  • 3.1. Endovascular Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Endovascular Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Endovascular Treatment Devices Market Opportunities
  • 3.4. Endovascular Treatment Devices Market Future Trends

4. Endovascular Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Endovascular Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Endovascular Treatment Devices Market Landscape

  • 6.1. Endovascular Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Endovascular Treatment Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Stents
    • 7.1.3. Balloon Catheters
    • 7.1.4. Inferior Vena Cava Filters
    • 7.1.5. Others

8. Endovascular Treatment Devices Market - By Procedure

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 8.1.2. Angioplasty
    • 8.1.3. Aneurysm Repair
    • 8.1.4. Thrombectomy
    • 8.1.5. Others

9. Endovascular Treatment Devices Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics
    • 9.1.5. Others

10. Endovascular Treatment Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Endovascular Treatment Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Endovascular Treatment Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Endovascular Treatment Devices Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Endovascular Treatment Devices Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Endovascular Treatment Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Endovascular Treatment Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
    • 11.2.2. Medtronic plc
    • 11.2.3. Abbott Laboratories
    • 11.2.4. Johnson & Johnson Services, Inc.
    • 11.2.5. Terumo Corporation
    • 11.2.6. Cook Group Incorporated
    • 11.2.7. Edwards Lifesciences Corporation
    • 11.2.8. W. L. Gore & Associates, Inc.
    • 11.2.9. Philips Healthcare
    • 11.2.10. Siemens Healthineers
    • 11.2.11. Cardinal Health
    • 11.2.12. Stryker Corporation
    • 11.2.13. Baxter International Inc.
    • 11.2.14. Asahi Intecc Co., Ltd.
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us